Published in J Diabetes Sci Technol on January 01, 2011
Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method. Clin Chem (1996) 1.40
Clinical pharmacokinetics and pharmacodynamics of insulin aspart. Clin Pharmacokinet (2001) 1.19
A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol (2007) 1.15
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care (1999) 1.05
Changes in basal insulin infusion rates with subcutaneous insulin infusion: time until a change in metabolic effect is induced in patients with type 1 diabetes. Diabetes Care (2009) 1.01
Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers. Eur J Clin Pharmacol (1999) 0.97
Comparative effect of human soluble insulin and insulin aspart upon hypoglycaemia-induced alterations in cardiac repolarization. Br J Clin Pharmacol (2003) 0.89
Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects. Diabetes Care (1991) 0.85
Comparison of a luminescent oxygen channeling immunoassay and an ELISA for detecting insulin aspart in human serum. J Pharm Biomed Anal (2009) 0.83
Comparison of plateau insulin levels achieved by intravenous or subcutaneous insulin infusion: evidence for low rates of subcutaneous degradation. Diabetes Care (1983) 0.81
Insulin clearance contributes to the variability of nocturnal insulin requirement in insulin-dependent diabetes mellitus. Diabetes (1985) 0.80
Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism (1984) 0.80
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet (2008) 12.43
SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet (2008) 8.63
Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract (2005) 8.07
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care (2005) 5.99
Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet (2009) 5.43
Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes (2007) 4.19
Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet (2008) 3.24
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet (2010) 2.81
A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care (2004) 2.65
An education and training course in motivational interviewing influence: GPs' professional behaviour--ADDITION Denmark. Br J Gen Pract (2006) 2.11
A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun (2008) 1.75
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects. Diabetes Care (2002) 1.73
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Small-molecule agonists for the glucagon-like peptide 1 receptor. Proc Natl Acad Sci U S A (2007) 1.71
Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab (2011) 1.67
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet (2009) 1.61
The course of low back pain in a general population. Results from a 5-year prospective study. J Manipulative Physiol Ther (2003) 1.55
Natural selection affects multiple aspects of genetic variation at putatively neutral sites across the human genome. PLoS Genet (2011) 1.54
The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care (2006) 1.52
Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes (2002) 1.46
Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am J Hum Genet (2013) 1.43
[Can systematic general health screening and patient-physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5-year follow-up]. Ugeskr Laeger (2002) 1.39
Genome-wide population-based association study of extremely overweight young adults--the GOYA study. PLoS One (2011) 1.34
General practitioners trained in motivational interviewing can positively affect the attitude to behaviour change in people with type 2 diabetes. One year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care (2009) 1.33
The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: implementation of a nationwide patient enrollment system. Clin Epidemiol (2012) 1.32
Premixed insulin treatment for type 2 diabetes: analogue or human? Diabetes Obes Metab (2007) 1.31
The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose. Diabetes (2003) 1.30
Perspectives on lifestyle intervention: the views of general practitioners who have taken part in a health promotion study. Scand J Public Health (2005) 1.29
General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract (2002) 1.18
Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scand J Public Health (2007) 1.17
Patient and GP agreement on aspects of general practice care. Fam Pract (2002) 1.17
Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes. PLoS One (2008) 1.17
Change in cardiovascular risk factors following early diagnosis of type 2 diabetes: a cohort analysis of a cluster-randomised trial. Br J Gen Pract (2014) 1.17
The effect of feedback to general practitioners on quality of care for people with type 2 diabetes. A systematic review of the literature. BMC Fam Pract (2009) 1.16
The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load. PLoS One (2009) 1.11
Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Göttingen minipigs in vivo. Am J Physiol Endocrinol Metab (2005) 1.07
Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Diabetes (2010) 1.07
Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab (2006) 1.07
Variants near MC4R are associated with obesity and influence obesity-related quantitative traits in a population of middle-aged people: studies of 14,940 Danes. Diabetes (2008) 1.05
Studies of metabolic phenotypic correlates of 15 obesity associated gene variants. PLoS One (2011) 1.03
Effect of "motivational interviewing" on quality of care measures in screen detected type 2 diabetes patients: a one-year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care (2011) 1.03
General practitioners' adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark. Scand J Prim Health Care (2010) 1.03
Incidence of GH deficiency - a nationwide study. Eur J Endocrinol (2006) 1.01
Identification of KCNJ15 as a susceptibility gene in Asian patients with type 2 diabetes mellitus. Am J Hum Genet (2010) 1.01
Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Educ Couns (2006) 1.00
The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol Scand (2004) 1.00
Electrocardiogram interpretation in general practice. Fam Pract (2004) 0.99
Protocol for ADDITION-PRO: a longitudinal cohort study of the cardiovascular experience of individuals at high risk for diabetes recruited from Danish primary care. BMC Public Health (2012) 0.99
You can't prevent everything anyway: a qualitative study of beliefs and attitudes about refusing health screening in general practice. Fam Pract (2004) 0.98
Discordance between self-evaluated health and doctor-evaluated health in relation to general health promotion. Scand J Prim Health Care (2004) 0.98
Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis. Clin Ther (2009) 0.97
Free fatty acids decrease circulating ghrelin concentrations in humans. Eur J Endocrinol (2006) 0.96
The prevalence of diabetic retinopathy in patients with screen-detected type 2 diabetes in Denmark: the ADDITION study. Acta Ophthalmol (2008) 0.96
Clinical evaluation of a transcutaneous interrogated fluorescence lifetime-based microsensor for continuous glucose reading. J Diabetes Sci Technol (2009) 0.96
The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age. Growth Horm IGF Res (2011) 0.95
Long-term impact of elevated cardiovascular risk detected by screening. A qualitative interview study. Scand J Prim Health Care (2005) 0.95
Somatropin and glucose homeostasis: considerations for patient management. Treat Endocrinol (2002) 0.94
Variation in the gene encoding Krüppel-like factor 7 influences body fat: studies of 14 818 Danes. Eur J Endocrinol (2009) 0.94
General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes. Scand J Prim Health Care (2008) 0.93
Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res (2006) 0.93
Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab (2008) 0.93
Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark. Scand J Prim Health Care (2009) 0.93
Self-reported cognitive and emotional effects and lifestyle changes shortly after preventive cardiovascular consultations in general practice. Scand J Prim Health Care (2009) 0.93
Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men. Diabetes (2011) 0.93
Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol (Oxf) (2002) 0.92
Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans. PLoS One (2011) 0.92
The aging population--is there a role for endocrine interventions? Growth Horm IGF Res (2008) 0.92
Implications of central obesity-related variants in LYPLAL1, NRXN3, MSRA, and TFAP2B on quantitative metabolic traits in adult Danes. PLoS One (2011) 0.92
Screening for type 2 diabetes and population mortality over 10 years. Lancet (2013) 0.92
Dilation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2011) 0.92
The -250G>A promoter variant in hepatic lipase associates with elevated fasting serum high-density lipoprotein cholesterol modulated by interaction with physical activity in a study of 16,156 Danish subjects. J Clin Endocrinol Metab (2008) 0.91
Diabetes prevalence and quality of diabetes care among Lebanese or Turkish immigrants compared to a native Danish population. Prim Care Diabetes (2007) 0.91
Acute hyperglycemia alters the ability of the normal beta-cell to sense and respond to glucose. Am J Physiol Endocrinol Metab (2002) 0.91
Association of variants in the sterol regulatory element-binding factor 1 (SREBF1) gene with type 2 diabetes, glycemia, and insulin resistance: a study of 15,734 Danish subjects. Diabetes (2008) 0.91
Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity. J Med Chem (2002) 0.91
The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes. Acta Ophthalmol Scand (2006) 0.90
Growth hormone and glucose homeostasis. Horm Res (2004) 0.90
What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS One (2013) 0.90
Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care (2011) 0.90
Mortality and GH deficiency: a nationwide study. Eur J Endocrinol (2007) 0.89
A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care (2008) 0.89
Limitations to subcutaneous insulin administration in type 1 diabetes. Diabetes Obes Metab (2003) 0.89
No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. Eur J Cardiovasc Prev Rehabil (2004) 0.89
NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs. Eur J Pharmacol (2002) 0.89
IDegAsp: a novel soluble insulin analogs combination. Expert Opin Biol Ther (2012) 0.89
Thoracic aortopathy in Turner syndrome and the influence of bicuspid aortic valves and blood pressure: a CMR study. J Cardiovasc Magn Reson (2010) 0.89
Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark. Scand J Prim Health Care (2011) 0.88
Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS One (2011) 0.87
Dual PPARalpha /gamma activation provides enhanced improvement of insulin sensitivity and glycemic control in ZDF rats. Am J Physiol Endocrinol Metab (2002) 0.87
Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. Clin Endocrinol (Oxf) (2007) 0.87
Carotid-femoral pulse wave velocity is associated with cerebral white matter lesions in type 2 diabetes. Diabetes Care (2012) 0.86